4.3 Editorial Material

What (or sometimes who) are organoids? And whose are they?

Journal

JOURNAL OF MEDICAL ETHICS
Volume 45, Issue 2, Pages 144-145

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/medethics-2018-105268

Keywords

chimeras; clinical trials; donation/procurement of organs/tissues; neuroethics; stem cell research

Ask authors/readers for more resources

In terms of ethical implications, Boers, van Delden and Bredenoord (2018) have made an interesting step forward with their model of organoids as hybrids, which seeks to find a balance between subject-like value and object-like value. Their framework aims to introduce effective procedures not to exploit donors and to increase their engagement, but it does not seem to take sufficient account of how organoids are used and how donors and society as a whole may want to act about such uses. I will concentrate my remarks on three points that I consider relevant. The first comment concerns the so-called mini-brains. The second one is related to the issue of consent and long-term 'control' over the organic material granted by donors. The last comment focuses on 'genetic minorities'.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available